1. Home
  2. Analysis
  3. Novorapid
  4. Psoriasis

Novorapid and Psoriasis - a phase IV clinical study of FDA data

Summary:

Psoriasis is reported as a side effect among people who take Novorapid (insulin aspart recombinant), especially for people who are female, 40-49 old, also take Paracetamol, and have High blood pressure.

The phase IV clinical study analyzes which people have Psoriasis when taking Novorapid. It is created by eHealthMe based on reports of 24,590 people who have side effects when taking Novorapid from the FDA, and is updated regularly.

What is Novorapid?

Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. eHealthMe is studying from 24,730 Novorapid users. Check the latest studies of Novorapid.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,474 drugs and 1,695 conditions by eHealthMe. Check the latest studies of Psoriasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

24,590 people reported to have side effects when taking Novorapid.
Among them, 80 people (0.33%) have Psoriasis.

Could Novorapid cause Psoriasis?

Among these 80 people:

What is the gender of people who have Psoriasis when taking Novorapid? *

  • female: 52.86 %
  • male: 47.14 %

What is the age of people who have Psoriasis when taking Novorapid? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 49.18 %
  • 50-59: 16.39 %
  • 60+: 34.43 %

What are other drugs people take besides Novorapid? *

  1. Levemir: 22 people, 27.50%
  2. Paracetamol: 22 people, 27.50%
  3. Keflex: 19 people, 23.75%
  4. Lyrica: 19 people, 23.75%
  5. Lantus: 18 people, 22.50%
  6. Fish Oil: 18 people, 22.50%
  7. Apidra: 18 people, 22.50%
  8. Cymbalta: 18 people, 22.50%
  9. Tecfidera: 17 people, 21.25%
  10. Humira: 17 people, 21.25%

What are other side effects people have besides Psoriasis? *

  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 28 people, 35.00%
  2. Headache (pain in head): 23 people, 28.75%
  3. Dizziness: 23 people, 28.75%
  4. Sensory Disturbance (sense disturbance): 23 people, 28.75%
  5. Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 21 people, 26.25%
  6. Fatigue (feeling of tiredness): 20 people, 25.00%
  7. Joint Pain: 19 people, 23.75%
  8. Skin Burning Sensation: 19 people, 23.75%
  9. Eye Pain: 19 people, 23.75%
  10. Eye Haemorrhage (bleeding in the eye): 19 people, 23.75%

What are the existing conditions these people have? *

  1. High Blood Pressure: 15 people, 18.75%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 11.25%
  3. Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 6 people, 7.50%
  4. Migraine (headache): 5 people, 6.25%
  5. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 6.25%
  6. Pain In Extremity: 5 people, 6.25%
  7. Indigestion: 3 people, 3.75%
  8. Neuropathy Peripheral (surface nerve damage): 3 people, 3.75%
  9. Depression: 2 people, 2.50%
  10. Diabetes Mellitus Inadequate Control: 2 people, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Novorapid and have Psoriasis?

- Check whether Psoriasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novorapid:

Psoriasis treatments and more:

How severe was Psoriasis and when was it recovered:

Expand to all the drugs that have ingredients of insulin aspart recombinant:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novorapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psoriasis:

Browse all the conditions that are associated with Psoriasis:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novorapid) and Novorapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.